Nora Hutchinson, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address533 Parnassus Avenue
San Francisco CA 94117
ORCID ORCID Icon0000-0003-1349-8592 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    McGill University, Montreal, QC, CanadaBA05/2006First Class Honors in History and First Class Honors in Anthropology
    McGill University, Montreal, QC, CanadaM.D.,C.M.05/2012Doctor of Medicine
    Cambridge University, Cambridge, United KingdomMPhil07/2013History and Philosophy of Science, Technology and Medicine
    Alpert Medical School, Brown University, Rhode Island Hospital, Providence, RI, USA06/2017Internal Medicine Residency Training
    McGill University, Montreal, QC, Canada06/2019Internal Medicine Fellowship Training

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Probability of Regulatory Approval Over Time: A Cohort Study of Cancer Therapies. JCO Oncol Pract. 2024 Feb; 20(2):247-253. Hutchinson N, Bicer S, Feldhake E, Carlisle BG, Gonen M, Del Paggio J, Kimmelman J. PMID: 38109682.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Large numbers of patients are needed to obtain additional approvals for new cancer drugs: A retrospective cohort study. Sci Rep. 2023 09 26; 13(1):16138. Ouimet C, Hutchinson N, Wang C, Matyka C, Del Paggio JC, Kimmelman J. PMID: 37752147; PMCID: PMC10522579.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Timing for First-in-Minor Clinical Trials of New Cancer Drugs. J Pediatr. 2023 Dec; 263:113705. Bicer S, Hutchinson N, Feldhake E, Nelson A, Oliviero E, Waligóra M, Kimmelman J. PMID: 37657661.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. How to limit uninformative trials: Results from a Delphi working group. Med. 2023 04 14; 4(4):226-232. Gelinas L, Hutchinson N, Zarin DA, Bierer BE. PMID: 37060899.
      View in: PubMed   Mentions:    Fields:    
    5. Disclosure of Possible Trial Termination to Participants of Interventional Clinical Trials. JAMA. 2023 04 04; 329(13):1116-1117. Hutchinson N, Gelinas L, Zarin D, Bierer BE. PMID: 37014347; PMCID: PMC10074217.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Competition for recruitment in SARS-CoV-2 Trials in the United States: a longitudinal cohort analysis. BMC Res Notes. 2022 Dec 12; 15(1):368. Hutchinson N, Klas K, Carlisle BG, Polak M, Kimmelman J, Waligora M. PMID: 36510308; PMCID: PMC9742655.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    7. The proportion of randomized controlled trials that inform clinical practice. Elife. 2022 08 17; 11. Hutchinson N, Moyer H, Zarin DA, Kimmelman J. PMID: 35975784; PMCID: PMC9427100.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    8. Quantifying Patient Investment in Novel Neurological Drug Development. Neurotherapeutics. 2022 09; 19(5):1507-1513. MacPherson A, Gumnit E, Ouimet C, Hutchinson N, Kieburtz K, Pearson TS, Kimmelman J. PMID: 35764764; PMCID: PMC9606150.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov. PLoS One. 2022; 17(1):e0262114. Hutchinson N, Klas K, Carlisle BG, Kimmelman J, Waligora M. PMID: 35061758; PMCID: PMC8782516.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    10. Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration. JAMA Netw Open. 2021 05 03; 4(5):e2110456. Hutchinson N, Carlisle B, Doussau A, Bosan R, Gumnit E, MacPherson A, Fergusson DA, Kimmelman J. PMID: 34003270; PMCID: PMC8132139.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases. Ann Intern Med. 2021 03; 174(3):326-334. MacPherson A, Hutchinson N, Schneider O, Oliviero E, Feldhake E, Ouimet C, Sheng J, Awan F, Wang C, Papenburg J, Basta NE, Kimmelman J. PMID: 33226855; PMCID: PMC7707230.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    12. The proportion of North American cancer trials that evaluate novel targets. Invest New Drugs. 2021 02; 39(1):256-259. Gumnit E, Feustel AC, Wong S, Bosan R, Hutchinson N, Kimmelman J. PMID: 32681475.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Ethical and Policy Issues for Seamless Phase I Oncology Trials. J Clin Oncol. 2020 03 01; 38(7):669-673. Hutchinson N, Vinarov E, Iasonos A, Kimmelman J. PMID: 31877086.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans